Limiting Speaker Program Risks in Light of The OIG’s Special Fraud Alert
So much has happened in the last few months in our industry especially in light of the OIG’s Special Fraud Alert on Speaker Programs that was issued toward the end of the year. I want to really get into some of those nuts and bolts, talk about what the OIG is telling us with
How to Manage the Post-COVID-19 World of Speaker Programs after OIG’s New Special Fraud Alert
As you can imagine, 2020 saw a huge reduction in speaker dinner programs due to COVID-19. The Office of Inspector General (OIG) and the Department of Justice (DOJ) took the opportunity to let biopharma know that these programs remain risky. In its most recent guidance, it stated, “Companies should assess
How Virtual SpeakerCasts® are Changing the Future of Biopharma Communications
The COVID –19 Pandemic has been a moving target. Every time it feels we have a pulse on its direction, the situation changes, leaving many in biopharma scrambling to keep programs on track. There’s a reason pharma and biopharma spend hundreds of millions of dollars on speaker programs annually. Speakers and
Go From a Good to a Great Product Director by Improving One Skill
Over the last twenty years in biopharma, I’ve found nearly every Product Director (PD) I’ve ever worked with to be intelligent, knowledgeable, and driven individuals who have worked hard to earn their positions. Good business skills come very naturally to most who have gone through the rigors to earn a
Industry Insights with Howard Drazner
Join us as we visit with Vision2Voice’s own Executive Vice President and General Manager, Howard Drazner, as he recaps the last 37 years of biopharma and peer-to-peer medical communications. We discussed how far the healthcare communications industry has come, where it’s going in the future, and whether or not the current
Case Study: Pivoting from an In-Person to a Virtual Advisory Board
A Pandemic Forces A Global Pharmaceutical Company to Step Out of Their Comfort Zone Into the Digital Realm Participating in an annual US event for allergy and immunology professionals each year was a key component for a global Pharmaceutical company’s marketing strategy. Having attended for years, countless hours of planning
Are Travel Restrictions Impacting Your Ability to Execute In-Person Meetings with HCPs?
As travel restrictions over environmental and health events beyond our control continue to mount, healthcare companies are increasingly looking at their options to avoid canceling or postponing important meetings, conferences, and large events. These meetings and events are, after all, crucial. Patients still need care and healthcare professionals still need
Driving Influences for Change in Prescribing Practices: High vs. Low Threshold Speakers
In the world of pharmaceutical marketing, the job of a speaker is to influence healthcare professionals (HCPs) to make the right decisions on behalf of their patients. Yet great medical treatments don’t always advance because it’s right or because the advantages are obvious. It is because of an HCP’s threshold
